New data shows Alzheimer's drug can benefit some patients
04:58
Share this -
copied
Dr. Madhav Thambisetty of Johns Hopkins School of Medicine joins Morning Joe to discus the results of a clinical trial of an experimental Alzheimer’s drug that suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease.Nov. 30, 2022
UP NEXT
Trump allies indicted in Arizona 2020 election probe
09:38
The Atlantic: What if Mike Johnson is actually good at this?
09:54
'I want to thank him': Joe reacts to 'fake news' heckler outside SCOTUS
02:41
How Vanderbilt University balances free speech and safety
08:41
Harvey Weinstein conviction overturned by New York's highest court
00:55
Neal Katyal: I really hope the Supreme Court moves fast on immunity case